Aristo Bio-Tech and Lifescience Ltd. - Research Center

---

Results

• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 25	Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21

Profit before tax

5.47

5.41

4.74

2.04

1.50

Net cashflow-operating activity

10.02

7.60

-2.78

6.82

2.28

Net cash used in investing activity

-5.15

-6.61

-3.75

-3.19

-1.98

Netcash used in fin. activity

-4.39

-2.21

7.97

-3.33

-0.72

Net inc/dec in cash and equivlnt

0.48

-1.22

1.44

0.30

-0.41

Cash and equivalnt begin of year

0.64

1.85

0.42

0.11

0.53

Cash and equivalnt end of year

1.12

0.64

1.85

0.42

0.11